Model evaluation results show that the distribution of the model simulations was also in line with the distribution of the tumor size and concentrations of mutant EGFR obtained from NSCLC patients (Supplementary Fig. S2). This evidence concerns the gene EGFR and non-small cell lung carcinoma.